Tag: Parkinson’s Disease

How Gut Health May Affect Alzheimer’s and Parkinson’s

AI SummaryThis article discusses how disturbances in the microbiome may impact the onset and severity of Alzheimer’s and Parkinson’s diseases. Research is being conducted to determine if mitigating these disturbances can slow or reverse the progression of these neurodegenerative diseases.Research into these neurodegenerative diseases is exploring how disturbances in our microbiome might influence their onset… Continue reading How Gut Health May Affect Alzheimer’s and Parkinson’s

New microscopy technique detects early Parkinson’s disease indicators

AI SummaryThis article discusses a new microscopy technique developed by researchers in Israel that can detect protein aggregation in cells, a key feature of Parkinson’s disease. This method can potentially allow for diagnosis up to 20 years before the onset of motor symptoms, opening up the opportunity for early treatment or prevention of the disease.… Continue reading New microscopy technique detects early Parkinson’s disease indicators

Scientists learn how to drug wily class of disease-causing enzymes

AI SummaryScientists have found a way to target GTPases, a type of molecular switches that are implicated in various diseases such as Parkinson’s and cancer. These enzymes were previously considered difficult to drug, but the new discovery opens up possibilities for developing treatments targeting these disease-causing mechanisms.Scientists have discovered how to target a class of… Continue reading Scientists learn how to drug wily class of disease-causing enzymes

[ASAP] Investigating the Mechanisms of Antibody Binding to Alpha-Synuclein for the Treatment of Parkinson’s Disease

AI SummaryThis article investigates the mechanisms of antibody binding to alpha-synuclein for the treatment of Parkinson’s Disease. The focus is on understanding how antibodies interact with this protein implicated in the disease, with the goal of developing new treatments. The research may lead to novel therapeutic approaches for Parkinson’s Disease by targeting alpha-synuclein. Molecular PharmaceuticsDOI:… Continue reading [ASAP] Investigating the Mechanisms of Antibody Binding to Alpha-Synuclein for the Treatment of Parkinson’s Disease

Fecal Microbiota Transplantation for Treatment of Parkinson Disease

AI SummaryThe article discusses a randomized clinical trial that assesses the safety and effectiveness of fecal microbiota transplantation in treating Parkinson’s disease.This randomized clinical trial evaluates the safety and efficacy of fecal microbiota transplantation for the treatment of Parkson disease.

Fecal Microbiome Transplants For Parkinson Disease

AI SummaryThis content discusses the use of fecal microbiome transplants (FMT) for Parkinson disease (PD). The gastrointestinal tract contains various microbes that impact health and disease through metabolic, immunologic, and neurosensory pathways. The gut microbiome has been identified as a potential target for various diseases, including PD. Recent studies, including one by Scheperjans et al,… Continue reading Fecal Microbiome Transplants For Parkinson Disease

Bilateral Focused Ultrasound Thalamotomy for Tremor—Is It Really Safe?

AI SummaryThe article discusses the safety and efficacy of bilateral focused ultrasound thalamotomy for essential tremor, with a study showing a significant 66% improvement in tremor/motor score after treatment. The study had a low attrition rate of 92% retention at 12 months.In this issue of JAMA Neurology, Kaplitt et al describe the results of a… Continue reading Bilateral Focused Ultrasound Thalamotomy for Tremor—Is It Really Safe?